How has OptimizeRx's common stock, par value (in dollars per share) changed year-over-year?

OptimizeRx's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.

What is the long-term trend for OptimizeRx's common stock, par value (in dollars per share)?

Over 5 years (2020 to 2025), OptimizeRx's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.

OptimizeRx OPRX Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Spok HoldingsSPOK

——

DoximityDOCS

——

Spectral AI, Inc.MDAI

——

UnitedHealth GroupUNH

——

Claritev CorporationCTEV

——

Teads Holding Co. Common StockTEAD

——

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's common stock, par value (in dollars per share)?: OptimizeRx (OPRX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has OptimizeRx's common stock, par value (in dollars per share) changed year-over-year?: OptimizeRx's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for OptimizeRx's common stock, par value (in dollars per share)?: Over 5 years (2020 to 2025), OptimizeRx's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.